A new generative AI model rapidly generates diverse antimicrobial peptide structures for screening against ...

Research into developing new antimicrobial resistance treatment in Nigeria and other low/middle-income countries has fuelled ...

Antimicrobial resistance is a growing problem and one ... That is our mission at CARB-X.” Filling out the pipeline CARB-X is a non-profit partnership organisation that aims to accelerate the ...

A team of microbiologists, chemists and pharmaceutical specialists at Shandong University, Guangzhou Medical University, ...

A groundbreaking $50 million investment has been announced to combat the growing threat of antimicrobial resistance (AMR) in ...

Research into developing new antimicrobial resistance treatments in Nigeria and other low/middle-income countries has secured ...

People with diabetes are more prone to developing Staphylococcus aureus, a leading cause of infections and death associated ...

The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...

and Qpex’s pipeline, including xeruborbactam, and its capabilities will accelerate our efforts to develop new antibiotic treatments to address antimicrobial resistance,” commented Shionogi's ...

The emergence of new human pathogens and increasing antimicrobial resistance in well-established pathogens are critical public health concerns. Unfortunately, the pipeline of new antimicrobial ...